Amikacin Sulphate 100mg Injection (per 2ml) — Liquid Injections
WHO-GMP Certified Commercial Pack · Product Code: AKP-051

Amikacin Sulphate 100mg Injection (per 2ml)

Formulation Overview: Ready-to-use neonatal/paediatric strength 100 mg/2 ml aminoglycoside sterile solution engineered with strict bacterial endotoxin limits for critical gram-negative infections. Formulated with Amikacin Sulphate IP (eq. Amikacin 100 mg per 2 ml) (100 mg / 2 ml) in Sterile Liquid Injection Vial / Ampoule dosage form under Anti-Infectives & Antibiotics, manufactured to IP / BP / USP Compendial standards and supplied in 2 ml Amber / Clear Glass Vial or Ampoule (Box of 5 / 10) with complete eCTD/ACTD regulatory dossiers, Zone IVb stability, and batch CoA for African NRAs (NAFDAC, PPB, SAHPRA, TMDA, FDA Ghana) and global tenders.
Item Code (SKU)AKP-051
Therapeutic SectorAnti-Infectives & Antibiotics
Dosage FormSterile Liquid Injection Vial / Ampoule
Active IngredientAmikacin Sulphate IP (eq. Amikacin 100 mg per 2 ml)
Strength / Purity100 mg / 2 ml
Clinical IndicationNeonatal sepsis, paediatric serious gram-negative bacteremia, and gentamicin-resistant UTI
Specification StandardIP / BP / USP Compendial
Packaging Format2 ml Amber / Clear Glass Vial or Ampoule (Box of 5 / 10)
Shelf Life24–36 Months
Storage ConditionsStore below 25°C; protect from freezing
Minimum Order Quantity1000 Packs
Regulatory / Analytical DocsFull eCTD / ACTD Modules 1–5 + Zone IVb Stability Available
African & Global NRA ReadinessNAFDAC (Nigeria), PPB (Kenya), SAHPRA (SA), TMDA (Tanzania), FDA Ghana, AIRP, ARP, EFDA
Stock AvailabilityIn Stock · Immediate Commercial Dispatch
Supply StatusCommercial Export Ready

Related Liquid Injections & Anti-Infectives & Antibiotics